Pramana
We imagine a world where we feel safe
A safe and accessible oral treatment for conditions associated with Immunometabolic dysfunction.
The Market
The unmet opportunities
Pramana's commitment
1,000,000,000+
People will suffer from diabetes by 2050
1,000,000,000,000+
Dollars in Global Healthcare Expenditures of Diabetes by 2050
100,000,000
Adults are affected by Latent Autoimmune Diabetes
Unmet Needs
The highest unmet need in the Diabetes space is the inability to maintain good long term glycemic control. By 2050 it is estimated that over 1 Billion people will be suffering from Diabetes. We need to address this epidemic with novel oral treatments that could provide meaningful benefit to patients.
Driven by Opportunity
Global Healthcare Expenditures of Diabetes is expected to reach $1Trillion by 2050. Our Team is focused on providing therapies that are best for the patient. We are working on oral treatments that could prevent, delay or cure patients suffering from Diabetes and associated immunometabolic disorders.
The opportunity for an oral treatment for Latent Autoimmune Disease in Adults that also addresses Hypoglycemia is just one of many areas of high unmet medical need associated with Immuno-metabolic disorders. We are committed to addressing this.
The Market
50%
Of people with Diabetes are currently undiagnosed
1
Person dies of Diabetes every 5 minutes
537,000,000
People currently live with diabetes
Pramana